A meta-analysis of the efficacy of vortioxetine in patients with major depressive disorder (MDD) and high levels of anxiety symptoms

Anxiety and DepressionBipolar Disorder

Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis

Lancet.

Cipriani A, Furukawa TA, Salanti G, Chaimani A, Atkinson LZ, Ogawa Y, Leucht S, Ruhe HG, Turner EH, Higgins JPT, Egger M, Takeshima N, Hayasaka Y, Imai H, Shinohara K, Tajika A, Ioannidis JPA, Geddes JR

doi: 10.1016/

Anxiety and Depression

Efficacy and safety of levomilnacipran, vilazodone and vortioxetine compared with other second-generation antidepressants for major depressive disorder in adults: A systematic review and network meta-analysis

J Affect Disord.

Wagner G, Schultes MT, Titscher V, Teufer B, Klerings I, Gartlehner G

doi: 10.1016/j.jad.2017.11.056.

Aging and Cognitive Functions

The Effects of Vortioxetine on Cognitive Function in Patients with Major Depressive Disorder: A Meta-Analysis of Three Randomized Controlled Trials

Int J Neuropsychopharmacol.

McIntyre RS, Harrison J, Loft H, Jacobson W, Olsen CK

doi: 10.1093/ijnp/pyw055.

Anxiety and Depression

Association of Depression and Anxiety Disorders With Autoimmune Thyroiditis: A Systematic Review and Meta-analysis

JAMA Psychiatry.

Siegmann EM, Müller HHO, Luecke C, Philipsen A, Kornhuber J, Grömer TW

doi: 10.1001/jamapsychiatry.

RECOMMENDED

Anxiety and Depression

Psychotic features in patients with major depressive disorder: A report from the European Group for the Study of Resistant Depression

J Clin Psychiatry.

Dold M, Bartova L, Kautzky A, Porcelli S, Montgomery S, Zohar J, Mendlewicz J, Souery D, Serretti A, Kasper S

doi: 10.4088/JCP.17m12090.

Anxiety and Depression

Moderating effect of comorbid anxiety disorders on treatment outcome in a randomized controlled psychotherapy trial in early-onset persistently depressed outpatients

Depress Anxiety.

Assmann N, Schramm E, Kriston L, Hautzinger M, Härter M, Schweiger U, Klein JP

doi: 10.1002/da.22839.

A randomized, double-blind, placebo-controlled 8-week trial of the efficacy, safety, and tolerability of 5, 10, and 20 mg/day vortioxetine in adults with major depressive disorder

Psychiatry Clin Neurosci.

Nishimura A, Aritomi Y, Sasai K, Kitagawa T, Mahableshwarkar AR

doi: 10.1111/pcn.12565.

Bipolar Disorder

Patterns of changes in bipolar depressive symptoms revealed by trajectory analysis among 482 patients with bipolar disorder

Bipolar Disord.

Behrendt-Møller I, Madsen T, Sørensen HJ, Sylvia L, Friedman ES, Shelton RC, Bowden CL, Calabrese JR, McElroy SL, Ketter TA, Reilly Harrington NA, Gao K, Thase M, Bobo WV, Tohen M, McInnis M, Kamali M, Kocsis JH, Deckersbach T, Köhler-Forsberg O, Nierenberg AA

doi: 10.1111/bdi.12715.

Anxiety and Depression

Trajectories of relapse in randomised, placebo-controlled trials of treatment discontinuation in major depressive disorder: an individual patient-level data meta-analysis

Lancet Psychiatry.

Gueorguieva R, Chekroud AM, Krystal JH

doi: 10.1016/

Related content

Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis

Efficacy and safety of levomilnacipran, vilazodone and vortioxetine compared with other second-generation antidepressants for major depressive disorder in adults: A systematic review and network meta-analysis

The Effects of Vortioxetine on Cognitive Function in Patients with Major Depressive Disorder: A Meta-Analysis of Three Randomized Controlled Trials

Association of Depression and Anxiety Disorders With Autoimmune Thyroiditis: A Systematic Review and Meta-analysis

Psychotic features in patients with major depressive disorder: A report from the European Group for the Study of Resistant Depression

Moderating effect of comorbid anxiety disorders on treatment outcome in a randomized controlled psychotherapy trial in early-onset persistently depressed outpatients

A randomized, double-blind, placebo-controlled 8-week trial of the efficacy, safety, and tolerability of 5, 10, and 20 mg/day vortioxetine in adults with major depressive disorder

Patterns of changes in bipolar depressive symptoms revealed by trajectory analysis among 482 patients with bipolar disorder

Trajectories of relapse in randomised, placebo-controlled trials of treatment discontinuation in major depressive disorder: an individual patient-level data meta-analysis